Formulation and optimization of mitochondria-targeted polymeric nanoparticles.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cell Biology

Background:

• Mitochondrial dysfunction is implicated in numerous diseases.
• Targeted drug delivery to mitochondria offers a promising therapeutic strategy.
• Existing methods often face challenges in drug property preservation and efficient mitochondrial uptake.

Purpose of the Study:

• To develop and characterize a functionalized polymer for creating mitochondria-targeted nanoparticles (NPs).
• To enable targeted delivery of therapeutics to cellular mitochondria without altering drug properties.
• To establish a protocol for synthesizing and preparing these NPs for potential therapeutic applications.

Main Methods:

• Synthesis of a mitochondria-targeting block copolymer: poly(DL-lactide-co-glycolide)-b-polyethylene glycol-triphenylphosphonium (TPP).
• Preparation of nanoparticles (NPs) using a nanoprecipitation method combined with polymer blending.
• Characterization of synthesized polymers and prepared NPs for size, charge, and functionality.

Main Results:

• Successful synthesis of a TPP-functionalized block copolymer for mitochondrial targeting.
• Preparation of well-defined nanoparticles with suitable size and charge for cellular uptake.
• Demonstrated potential for efficient mitochondrial trafficking of payload-loaded NPs.

Conclusions:

• The developed functionalized polymer enables the creation of mitochondria-targeted nanoparticles (NPs).
• This approach facilitates drug delivery to mitochondria, offering a novel strategy for treating mitochondrial diseases.
• The protocol provides a foundation for developing advanced nanomedicines for mitochondrial disorders.